35-swine flue 09
TRANSCRIPT
-
8/17/2019 35-Swine Flue 09
1/36
Swine fu (Swine infuenza,H1N1 FLU)
BYBY
-
8/17/2019 35-Swine Flue 09
2/36
Outline
• Introduction
• Historical Perspective of Swine Flu
• Inuenza viruses-virology
• Mode of transmissions
• Other informations
-
8/17/2019 35-Swine Flue 09
3/36
Introduction
! "here is glo#al evidence of inuenza $%H& causingmor#idity and mortality!
'! (HO has raised the level of inuenza pandemic alertto )!
*! Inuenza must #e ta+en seriously, precisely #ecauseof their capacity to spread to every country!
! Most cases seem to #e mild and self limited howeversevere illness and death have #een reported in a
small proportion of cases!
-
8/17/2019 35-Swine Flue 09
4/36
O#.ectives
! "o detect and con/rm cases of newInuenza $%H&virus infection!
'! "o esta#lish and monitor the e0tend ofspread of new Inuenza $%H& contacts!
*! "o esta#lish treatment protocols!! "o assist the hospitals sta1 in infection
control!
2! "o use the personal protective e3uipmentand removal and disposal with safely!
)! "o train medical personnel in collectingsamples and to store them and safely
transport to the national la#!
-
8/17/2019 35-Swine Flue 09
5/36
"IM4 5I&4 OF 464&"S
April 12: An out#rea+ of inuenza-li+e illness in Veracruz, Mexico,
reporte to !H"• April 1#$1%: two ca&e& o' a new $7H&8 virus infection
ientie in two &outern 9alifornia countie& in U*S*A*
• April 2+: new inuenza $ 7H&8 virus infection conre in&e-eral patient& in Me0ico
• April 2.: !H" eclare& a pu/lic ealt e-ent o'international concern (PH4I9)*
• 0une 11: !H" eclare& paneic phase ) (&prea to 2 !H"reion&)
• n 3 wee4&, all !H" reion& reportin ca&e& o' paneic
(H1N1) 2553
6rea4in New&
• 7lo/al &wine fu eat& pa&& 15,555 wit ore tan +2#555conre ca&e& e8ectin ore tan 259 countrie&*
•
Accorin to unocial &ource, 93 ca&e& in ;un
-
8/17/2019 35-Swine Flue 09
6/36
Mode of spread
! "he virus is spread from person to person #ye0posure to infected droplet e0pelled #ycoughing or sneezing7*: ;8!
'! 9ontaminated hands and surfaces7
-
8/17/2019 35-Swine Flue 09
7/36
HumanHuman
virusvirus
ReassortantReassortant
virusvirus
Non-Non-
humanhuman
virusvirus
Mecani&& o' nfuenza Viru&Mecani&& o' nfuenza Viru&
Aaptation to Huan nfuenza -iru&Aaptation to Huan nfuenza -iru&
(>&i't?)(>&i't?)
D I R E C T
D I R E C T
-
8/17/2019 35-Swine Flue 09
8/36
6irology
INFLUENZA VIRUSESINFLUENZA VIRUSES
Family orthomyxoviridaeFamily orthomyxoviridae Influenza A H1N1, and H1N2,Influenza A H1N1, and H1N2,
H3N2 may beH3N2 may be RNA virus segmented genomesRNA virus segmented genomes a!h segment en!odes a differenta!h segment en!odes a different
"rotein "rotein #$o ma%or surfa!e "roteins#$o ma%or surfa!e "roteins
&Hemagglutining &HA',&Hemagglutining &HA',nuraminidase &NA'nuraminidase &NA' that determinthat determinthe seroty"esthe seroty"es
-
8/17/2019 35-Swine Flue 09
9/36
9ase =e/nition
Su&pecte ca&e o' paneic (H1N1) 251=! $ suspected case is de/ned as an individual
with acute respiratory illness and fever7reported or documented fever 7more than
*>?98 and one of the following@ cough, sorethroat, shortness of #reath, diAculty in#reathing or chest pains with onset@
- (ithin seven days of close contact with aperson who is pro#a#le or con/rmed case!
- (ithin seven days of travel to acountry%community where there is one or more
con/rmed cases of pandemic!
-
8/17/2019 35-Swine Flue 09
10/36
Pro#a#le case of pandemic
! $ pro#a#le case is de/ned as an individual withan inuenza li+e illness who is positive forinuenza $ that unsu#typea#le #y P9B
individual with a clinically compati#le illness orwho died of an une0plained acute respiratoryillness who is considered to #eepidemiologically lin+ed to a pro#a#le or
con/rmed case!
-
8/17/2019 35-Swine Flue 09
11/36
9on/rmed case of pandemic7H&8 ':)
! $ con/rmed case is de/ned as an individualwith an inuenza li+e illness with la#oratorycon/rmed pandemic $%H& '::C virus
infection #y one more of the following testD- P9B
- 4lisa
- 6iral culture- Four fold rise in pandemic 7H&8 ':) virus
speci/c neutralizing anti#odies!
-
8/17/2019 35-Swine Flue 09
12/36
=anger Signs
• Shortness of #reath, either during physicalactivity or while resting!
• =iAculty in #reathing
• "urning #lue
• Eloody coloured sputum
• 9hest pain
•
$ltered mental status• High fever that persists #eyond * days
• 5ow #lood pressure!
-
8/17/2019 35-Swine Flue 09
13/36
=anger signs in 9hildren
• Fast or diAcult #reathing
• 5ac+ of alertness
• =iAculty in wa+ing up
• 5ittle or no desire
• convulsions
-
8/17/2019 35-Swine Flue 09
14/36
$verage age of cases
• Occurring in younger people with the medianage reported to #e '-< years
• $verage age of cases now increasing from :-
2 years• $ge group #elow 2-' years also suscepti#le
-
8/17/2019 35-Swine Flue 09
15/36
Bis+ factors
• 9ardiovascular disease
• Bespiratory disease i!e! $sthma etc!
• =ia#etes
• 9ancer
• Immunosuppressant illnesses
• Hepatic and renal diseases
• (ith poor socioeconomics status
• pregnancy
-
8/17/2019 35-Swine Flue 09
16/36
Proposed Strategy for 9ontrol ofPandemic H&
• 9ontainment PhaseD $lmost over, so airportsurveillance has limited e1ect
• Out#rea+ management PhaseD "hrough
awareness 7li+e social distancing8, improveddiagnosis, updated u response centres, stoc+pilling drugs, plan to manage socialdistur#ances, monitor /rst case contacts
• "reatment PhaseD Eased on clinical diagnosis!
-
8/17/2019 35-Swine Flue 09
17/36
9linical scenario
Varia/le& "ccurrenceS@pto&
9hilly sensation GGGG
9ough GGG
Headache GGGSore throat GGG
Prostration GG
&asal stuAness GG
=iarrhea GG=izziness G
4ye irritation or pain G
6omiting G
Myalgia G
-
8/17/2019 35-Swine Flue 09
18/36
Sin&
Fever GGGG
Pharyngitis GGG
9on.unctivitis 7mild8 GG
Bhinitis GG9ervical lymphadenopathy G
Pulmonary rales, wheezes, or rhonchi
G
-
8/17/2019 35-Swine Flue 09
19/36
in the assessment of persons withmild or uncomplicated inuenza
illness
-
8/17/2019 35-Swine Flue 09
20/36
$ntiviral =rugs for "reatment ofInuenza
• "he neuraminidase inhi#itors are the drugs ofchoice
1*"&eltai-ir - $s capsules or oral suspension
7"amiu82*anai-ir - For oral inhalation 7Belenza8
+*;erai-ir - $ third neuraminidase inhi#itor
peramivir formulated for intravenous 7I68administration is an investigational product
Speci/c Begimens for "reatment and 9hemoprophyla0is of
-
8/17/2019 35-Swine Flue 09
21/36
Speci/c Begimens for "reatment and 9hemoprophyla0is of'::C H& Inuenza $
"reatment and 9hemoprophyla0is Begimens for $dultsand 9hildren #y $ge and (eight
#able 1( Antiviral medi!ation dosing re!ommendations#able 1( Antiviral medi!ation dosing re!ommendations
for treatment or !hemo"ro"hylaxis of 2))* Hfor treatment or !hemo"ro"hylaxis of 2))* H11 N N11
infe!tioninfe!tion
+edi!ation+edi!ation #reatment#reatment& days'& days'
-hemo"ro"hylaxis-hemo"ro"hylaxis&1) days'&1) days'
.seltamivir .seltamivir 11
AdultsAdults/ mg/ mg
t$i!et$i!e
dailydaily
/ mg on!e daily/ mg on!e daily
-hildren-hildren 00 12 months12 months
d i h d i ht d i h d i ht
-
8/17/2019 35-Swine Flue 09
22/36
ody eightody eight
&g'&g'ody eightody eight
&lbs'&lbs'
441 g1 g 4433lbs33lbs 3) mg t$i!e3) mg t$i!e
dailydaily
3) mg on!e3) mg on!e
dailydaily
0 1 g to 230 1 g to 23
gg0 33 lbs to 10 33 lbs to 1
lbslbs5 mg t$i!e5 mg t$i!e
dailydaily5 mg on!e5 mg on!e
dailydaily
0 23 g to 5)0 23 g to 5)gg
0 1 lbs to 660 1 lbs to 66lbslbs
7) mg t$i!e7) mg t$i!edailydaily
7) mg on!e7) mg on!edailydaily
0 5) g0 5) g 0 66 lbs0 66 lbs / mg t$i!e/ mg t$i!e
dailydaily/ mg on!e/ mg on!e
dailydaily
-hildren 3 months to 0 12 months-hildren 3 months to 0 12 months22
3 mg8g8dose3 mg8g8dose
t$i!e dailyt$i!e daily3 mg8g8dose3 mg8g8dose
on!e "er dayon!e "er day
-hild ) t 3 th-hild ) t 4 3 th 33
-
8/17/2019 35-Swine Flue 09
23/36
-hildren ) to 4 3 months-hildren ) to 4 3 months33
3 mg8g8dose3 mg8g8dose
t$i!e dailyt$i!e daily
Not re!ommended Not re!ommended
unless situationunless situation %udged !riti!al due to %udged !riti!al due to
limited data on uselimited data on use
in this age grou"in this age grou"
9anamivir 9anamivir 55
AdultsAdults
1) &t 1) &t 1) &t 1) &t
-
8/17/2019 35-Swine Flue 09
24/36
1) mg &t$o :1) mg &t$o :
mgmg
inhalations'inhalations'
t$i!e dailyt$i!e daily
1) mg &t$o :mg1) mg &t$o :mg
inhalations' on!e dailyinhalations' on!e daily
-hildren &-hildren &00 / years or older for treatment,/ years or older for treatment, 00 years for years for
!hemo"ro"hylaxis'!hemo"ro"hylaxis'
1) mg &t$o :1) mg &t$o :
mgmg
inhalations'inhalations'
t$i!e dailyt$i!e daily
1) mg &t$o :mg1) mg &t$o :mg
inhalations' on!e dailyinhalations' on!e daily
-
8/17/2019 35-Swine Flue 09
25/36
Preventive tips
ash hands fre;uently $ith soa" and $ater ash hands fre;uently $ith soa" and $ater -over mouth < nose $hen !oughing or sneezing-over mouth < nose $hen !oughing or sneezing Avoid tou!hing your eyes, nose and mouthAvoid tou!hing your eyes, nose and mouth =eo"le $ho are si! $ith an influenza:lie illness &I>I'=eo"le $ho are si! $ith an influenza:lie illness &I>I'
&fever "lus at least !ough or sore throat and "ossibly other&fever "lus at least !ough or sore throat and "ossibly othersym"toms lie runny nose, body a!hes, heada!hes, !hills,sym"toms lie runny nose, body a!hes, heada!hes, !hills,fatigue, vomiting and diarrhea' should stay homefatigue, vomiting and diarrhea' should stay home
?ee" a$ay from others@ avoid travel, for at least 25 hours?ee" a$ay from others@ avoid travel, for at least 25 hours
after fever is gone( &Fever should be gone $ithout the useafter fever is gone( &Fever should be gone $ithout the useof fever:redu!ing medi!ine'(of fever:redu!ing medi!ine'( Avoid !lose !onta!t &i(e( being $ithin about 7 feet' $ithAvoid !lose !onta!t &i(e( being $ithin about 7 feet' $ith
"ersons $ith I>I( "ersons $ith I>I(
-
8/17/2019 35-Swine Flue 09
26/36
Indications for vaccination
;er&on& at i ri&4 'or coplication 'ro te fu
• $ll children )-2C months of age• Person )2 yr of age
• $dults and children ) mo of age with chronic heart orlung conditions, including asthma
•
$dults and children ) mo of age who needed regularmedical care or were in a hospital during the previousyear #ecause of a meta#olic disease 7li+e dia#etes8,chronic +idney disease, or immune system, includingimmune system pro#lems caused #y medicines or #y
infection with HI6%$I=S!• 9hildren ) months to > yr of age who are on long term
aspirin therapy #ecause of the increased ris+ for Beyesyndrome!
• (omen who will #e pregnant during the inuenza season
;er&on& #5$=. @r o' ae
;er&on& wo can tran&it fu to oter&
-
8/17/2019 35-Swine Flue 09
27/36
;er&on& wo can tran&it fu to oter&
"his includes all health care wor+ers, householdcontacts and out of home caregivers of children
:-'* mo of age, and close contact of persons )2 yr of age!
6 i il #l
-
8/17/2019 35-Swine Flue 09
28/36
6accines availa#le;anerix: 7Monovalent Inuenza $ H& ':)8
Healt@ cilren ae o-er &ix ont& an /elow15 @ear&D- $ single dose of :!'2ml!
uno coproi&e cilren ae o-er &ixont& an /elow 15 @ear&:- "wo doses of :!'2ml given at least three wee+sapart!
Healt@ cilren ae 15 @ear& an o-er orealt@ ault&:- $ single dose of :!2ml!
uno coproi&e cilren ae 15 @ear& ano-er or iuno coproi&e ault&:- "wo doses of :!2ml given at least three
wee+s apart!
C l 7Mono alent Inuen a $ H&
-
8/17/2019 35-Swine Flue 09
29/36
Cel-apan: 7Monovalent Inuenza $ H&':)8
All cilren ae o-er &ix ont& an/elow 15 @ear&:- "wo doses of :!2ml given at least threewee+s apart!
All cilren ae 15 @ear& an o-er orault&: - "wo doses of :!2ml given at least three
wee+s apart6accine manufacturers are Sonoo/ Pasteur,
&ovartis, Intranasal #y MedImmune, 559,
9S5 5imited!
-
8/17/2019 35-Swine Flue 09
30/36
Levels of Prevention
! Health Promotion
'! Speci/c Protection
*! 4arly diagnosis and prompttreatment
! =isa#ility limitation
2! Beha#ilitation
-
8/17/2019 35-Swine Flue 09
31/36
MDEH"S "F C"NEG"L
1* ;re-enti-e ea&ure&• Health 4ducation for pu#lic and health personnel
• Immunoprophyla0is
• 9hemoprophyla0is
2* Control o' patient, contact& an teieiate en-ironent
• Beport to local health authority
• Isolation
• 9oncurrent disinfection
• Kuarantine
• Protection of contencts
-
8/17/2019 35-Swine Flue 09
32/36
• Investigation of contacts
• Speci/c treatment
+*Dpieic Mea&ure&
.*i&a&ter iplication&#*nternational ea&ure&
-
8/17/2019 35-Swine Flue 09
33/36
Non CommunicableDiseases
1* ;ro/le& wit natural i&tor@ o'i&ea&e
• $#sence of a +nown agent• Multifactorial causation
• 5ong latent period
• Inde/nite onset
-
8/17/2019 35-Swine Flue 09
34/36
Burden of Disease-Measurement
! Proportional mortality ratio
'! 5oss of life e0pectancy
*! 9H= incidence rate
! $ge-speci/c death rates prevalence rate
2! 9ase fatality rate
)! Measurement of ris+ factor levels
-
8/17/2019 35-Swine Flue 09
35/36
-
8/17/2019 35-Swine Flue 09
36/36
PREVEN!VE "R#E$!E"1* ;opulation Strate@
• Prevention in whole populations
"%eci&c !nterventions e'(
i8 =ietary changes
ii8 Smo+ingiii8 Elood pressure
iv8 Physical activity
• Primordial prevention in whole populations
2* Hi Gi&4 Strate@
+* Seconar@ pre-ention
Darl@ iano&i& An Ereatent